Nivolumab Biosimilar - Research Grade
Product Sizes
1 mg
ICH4009-1MG
5 mg
ICH4009-5MG
10 mg
ICH4009-10MG
20 mg
ICH4009-20MG
50 mg
ICH4009-50MG
100 mg
ICH4009-100MG
200 mg
ICH4009-200MG
500 mg
ICH4009-500MG
1 g
ICH4009-1G
About this Product
- SKU:
- ICH4009
- Additional Names:
- Programmed cell death protein 1, Pdcd1, CD279
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1-5 mg/ml
- Extra Details:
- Nivolumab biosimilar is a human monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. Nivolumab is an IgG4 kappa immunoglobulin that has a calculated molecular mass of 146 kDa. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line.
- Formulation:
- Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
- Host:
- Human
- Immunogen:
- PD-1
- Isotype:
- IgG4, kappa
- Purity:
- >95%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Nivolumab.
- Storage Conditions:
- 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/nivolumab-biosimilar-research-grade-ich4009/
